Genetic variation in prostaglandin E2 synthesis and signaling, prostaglandin dehydrogenase, and the risk of colorectal adenoma.
Genetic variation in prostaglandin E2 synthesis and signaling, prostaglandin dehydrogenase, and the risk of colorectal adenoma.
复制标题
DOI:
10.1158/1055-9965.epi-09-0869
复制
发表时间:
2010-02
期刊:
影响因子:
--
通讯作者:
Ulrich CM
中科院分区:
文献类型:
--
作者:
Poole EM;Hsu L;Xiao L;Kulmacz RJ;Carlson CS;Rabinovitch PS;Makar KW;Potter JD;Ulrich CM
Prostaglandins are important inflammatory mediators; PGE2 is the predominant prostaglandin in colorectal neoplasia and affects colorectal carcinogenesis. Prostaglandins are metabolites of omega-6 and omega-3 polyunsaturated fatty acids; their biosynthesis is the primary target of nonsteroidal anti-inflammatory drugs (NSAIDs), which reduce colorectal neoplasia risk. We investigated candidate and tagSNPs in PGE2 synthase (PGES), PGE2 receptors (EP2 and EP4), and prostaglandin dehydrogenase (PGDH) in a case-control study of adenomas (n=483) vs. polyp-free controls (n=582) and examined interactions with NSAID use or fish intake, a source of omega-3 fatty acids. A 30% adenoma risk reduction was observed for EP2 4950G>A (intron 1; ORGA/AA vs. GG: 0.71; 95% CI: 0.52-0.99). For the candidate polymorphism EP4 Val294Ile, increasing fish intake was associated with increased adenoma risk among those with variant genotypes, but not among those with the Val/Val genotype, (p-interaction=0.02). An interaction with fish intake was also observed for PGES -664A>T (5’UTR; p-interaction=0.01). Decreased risk with increasing fish intake was only seen among those with the AT or TT genotypes (OR>2 t/wk vs. <1 t/wk: 0.56; 95% CI: 0.28-1.13). We also detected interactions between NSAIDs and EP2 9814C>A (intron 1) and PGDH 343C>A (intron 1). However, none of the observed associations was statistically significant after adjustment for multiple testing. We investigated potential gene-gene interactions using the Chatterjee 1df Tukey test and logic regression; neither method detected significant interactions. These data provide little support for associations between adenoma risk and genetic variability related to PGE2, yet suggest gene-environment interactions with anti-inflammatory exposures.